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ABSTRACT 
Objective: Study of CNS activities of piperine perse and its bio-enhancing effect on various drugs in experimental animal models. 
Methods: The CNS effects of piperine and its interaction with various drugs were evaluated by maximal electroshock convulsion model, 
pentobarbitone-induced sleeping time, anxiolytic activity, muscle relaxant activity and antidepressant activity using tail suspension and forced 
swimming test using standard procedures in experimental animal models. piperine at a dose of 10 and 20 mg/kg orally was used to evaluate CNS 
activities.  
Results: The results revealed that piperine perse posses only anticonvulsant activity and other significant CNS effects were not observe. But when it 
was combined with various drugs piperine increases the effect of the standard drug.  
Conclusion: Piperine 10 mg/kg has the potential to be used as a bio-enhancing agent when combined with other drugs. Bio-enhancing effect of 
piperine will decrease the dose of the standard drug, thereby decreasing the risk of their toxicity. 
Keywords: Piperine, Bio-enhancing, MES, Anxiolytic test, Tail suspension test, Forced swimming test, Motor co-ordination, Righting reflex  
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INTRODUCTION 
WHO data suggest that neurological and psychiatric disorders are 
important and growing cause of morbidity. Around 450 million 
people currently suffer from mental and behavioral disorders [1]. 70 
% of mental health problems have their onset during childhood or 
adolescence. Young people aged 15 to 24 are more likely to 
experience mental illness and/or substance use disorders than any 
other age group [2]. Medicinal plants are one of the oldest 
healthcare products used widely. The importance of plant products 
has also increased in developed countries.  
Though many allopathic drugs are available to treat mental health 
but some of these drugs have late onset or associated with various 
side effects. Plant products have wide therapeutic action along with 
a better safety profile. Hence, a study was planned to evaluate 
various CNS activity of Piperine and its interaction with other 
standard drugs. Piperine is the chief constituent of piper nigrum, 
which is commonly known as black pepper and is one of the oldest 
and best-known spices in the world. Belonged to Piperaceae family, 
which is cultivated in the damp nutrient rich soil of South India, it is 
also found in Indonesia, Malaysia, and Brazil. In India, it is called 
“kali mirchi”, which is a common household spice. 
Its chief constituents are crystalline alkaloid piperine (5-8.25 %), 
volatile oils (1-2.3 %) and a resin called Chavicin [3]. Black pepper 
was found to enhance intestinal absorption of methionine and 
calcium ions [4]. Piperine, the best-known compound of pepper was 
reported to inhibit fatty acid oxidation in rat liver microsomes [5]. It 
is also proved that it increases the bioavailability of theophylline, 
propanolol, and nutrients [6]. In the view of these facts, perse 
activity of piperine and its interaction with other drugs was 
undertaken. 
MATERIALS AND METHODS 
Plant material and isolation of piperine [7] 
Piperine was obtained from Amsar (P) Ltd, Indore (M. P.), which 
contained about 95 % of piperine. 
The extract was dissolved in 5 ml of Ethyl alcohol and 10 ml of 10 % 
w/v of alcoholic potassium hydroxide added with constant stirring. 
It was then filtered and allowed to stand overnight. The yellow 
needle-shaped crystals of piperine were separated the next day.  
The purity of the isolated piperine was verified by checking its melting 
point (range 128-131 °C), treating it with concentrated Sulphuric acid 
(blood red color obtained), by Thin Layer Chromatography (single 
spot obtained) and Ultraviolet Spectrophotometer (absorption 
maxima at 343 nm for piperine). [8, 9] 
Experimental animals 
Swiss albino mice and wistar rats of either sex weighing between 
25-35 gm and 150-200 gms respectively, were procured from the 
central animal house, M. G. M Medical College, Indore and 
acclimatized for a period of 7 d at room temperature (25±2 °C) and 
50±15 % relative humidity. They were housed in a standard cage 
and maintained on standard pellets and water ab libitum. The 
animals described as ‘fasted’ were deprived of food for 16 h, but had 
free access to water. The study was carried out in the Department of 
Pharmacology, M. G. M Medical College, Indore (M. P.), India. The 
study protocol was approved by the Institutional Animal Ethics 
Committee (IAEC). 
Drugs and chemicals 
Gum acacia (Himedia Lab, India), Epsolin injection-PHENYTOIN 
SODIUM-50 mg/ml-Cadila–H Pharm. Ltd., Tegrital tablet-
CARBAMAZEPINE-200 mg-Novartis, Powder PENTOBARBITONE-
Rhone Poulenc India Ltd., Midaz injection-MIDAZOLAM-5 mg/ml-
Nicholas limited, Calmpose injection-DIAZEPAM-10 mg/2 ml-
Ranbaxy limited were purchased from their respective 
representatives. 
Preparation of drugs for animal experiment 
Piperine and other drugs were given orally. All Drugs were dissolved 
in 2 % gum acacia which acted as a vehicle. 
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(i) Effect of piperine per se and its interaction with carbamazepine in 
“electroshock convulsion in albino mice.” 
The albino mice were divided into eight groups of 8 each. The eight 
groups were treated respectively as under Group I received 2 % gum 
acacia 10 ml/kg, Group II received phenytoin 0.5 mg/kg, Group III 
received Carbamazepine 15 mg/kg, Group IV received 
Carbamazepine at a sub-anticonvulsant dose of 7.5 mg/kg [10], 
Group V received piperine 10 mg/kg, Group VI received piperine 20 
mg/kg, Group VII received piperine 40 mg/kg and Group VIII 
received a combination of carbamazepine and piperine (7.5 
mg/kg+10 mg/kg). All drugs were administered orally one hour 
prior to the application of electroshock. The electroshock was given 
by electrodes which were applied to pinna of a mouse. 50 mA 
current was given for 0.2 s. Different stages of MES were noted ( an 
observation on the hind limb extension was mainly focused). 
Reduction in time or the abolition of tonic extensor phase was noted. 
A complete abolition of hind limb tonic extension was considered as 
100 % protection [11]. 
(ii) The effect of piperine per se and its interaction with 
“pentobarbitone induced loss of righting reflex in albino rats.” 
The study was done in 48 male albino rats, divided into six groups of 
8 animals each. The six groups were treated respectively as:-Group I 
received 2 % gum acacia 10 ml/kg, Group II received 
pentobarbitone 40 mg/kg [12], Group III received piperine 10 
mg/kg, Group IV received piperine 20 mg/kg, Group V received 
piperine 40 mg/kg and Group VI received a combination of 
pentobarbitone and piperine (40+10 mg/kg).  
Time of onset of loss of righting reflex and duration of loss of 
righting reflex was recorded. The animals were placed in supine 
with their back on the surface. Time of recovery was noted when 
animals correct its posture from supine to pronated one (normal). 
The time of recovery provides us the duration of loss of righting 
reflex.  
(iii) Effect of piperine per se and its influence on anxiolytic property 
of midazolam in albino mice using “elevated plus maze (EPM)” 
instrument 
The elevated plus-maze was introduced by Pellow et al. [13] for rats 
and by Listetil et al. [14] for mice. The EPM apparatus consisted of 
two open arms (30 x 5 cm) and two closed arms (30 x 5 x 20 cm) 
emanating from a common central platform (5 x 5 cm). The two 
pairs of identical arms were opposite to each other. The entire 
apparatus was elevated to a height of 50 cm above the floor level. 
The albino mice were divided into four groups of 8 each. The four 
groups were treated respectively as Group I-2 % gum acacia (10 
ml/kg), Group II midazolam (0.2 mg/kg), Group III piperine (10 
mg/kg) and Group IV midazolam and piperine (0.2 mg/kg+10 
mg/kg).  
Procedure-The animals received the treatment as per the schedule, 
1 hour before the start of the session. At the beginning of the session, 
a mouse was placed at the center of the maze, its head facing the 
closed arms and total entries in different arms were recorded. An 
entry was defined as the presence of all four paws in the arm. The 
EPM was carefully wiped, with 10 % ethanol after each trial, to 
eliminate the possible bias due to the odor of the previous animal. 
(iv) Effect of piperine per se and its influence on skeletal muscle 
relaxant property of diazepam in albino mice using “Techno ROTA 
ROD” instrument 
The albino mice were divided into four groups of 8 each. The four 
groups were treated respectively as: Group I-2 % gum acacia (10 
ml/kg), Group II diazepam (3 mg/kg) [15], Group III piperine (10 
mg/kg) and Group IV diazepam and piperine (3 mg/kg+10 mg/kg).  
Procedure-Motor coordination and balance were tested using 
accelerating rotarod (Techno Rota Rod System). Mice were placed 
on a horizontal metal rod (3 cm diameter) rotating at an initial 
speed of 10 rpm/min. the terminal speed of the rod was 20 rpm in 
accelerated studies, and rotational velocity of the rod was linearly 
increased from 10 to 20 rpm within 20 s. The time each animal was 
able to maintain its balance walking on top of the rod was measured. 
Before the beginning of all experiments, the riding ability of the 
animals in the rotarod was checked. Mice were first trained on the 
rotating rod of the instrument at 25 rounds/minute till mice could 
balance to keep themselves on rotating rod or till the end of 60 
seconds [16]. 3 to 4 trials per day were given for 2 d to all the 
animals. Those mice that successively completed three trials/day for 
2 d were selected. Mice that immediately dropped off (within 30 s) 
were removed from the experiment [17]. The number of seconds 
each mouse remained on the rotarod was recorded for 60 seconds 
on the third day. 
(v) Effect of piperine per se and its interaction with sertraline HCl in 
albino mice by using “tail suspension test” (TST) 
TST was performed according to Steru et al. [18] with slight 
modifications. In brief, a group of 32 mice were divided at random 
into four groups (n=8) and treated as follows: Group, I (control) 
received 2 % gum acacia 10 ml/kg, Group II received sertraline (5 
mg/kg), Group III received piperine (10 mg/kg) and Group IV 
received piperine+sertraline (10+5 mg/kg). All drugs were 
administered orally 2 hours prior to the TST. Mice were suspended 
by the tail at the height of 58 cm. above the table top using adhesive 
tape affixed to the hook. Each mouse was suspended individually. 
The movements of the mice were measured for 10 min. 
(vi) Effect of piperine per se and its interaction with sertraline HCl in 
albino rats by using “forced swimming test” (FST):  
This paradigm was performed as described previously by Porsolt et 
al. [19] and Siuciak et al. [20] with some modifications [21, 22] and 
presently considered as the standard method. 
Rats were individually forced to swim in an open cylindrical 
container (diameter 30 cm, height 60 cm); containing water of 45 cm 
depth at 25±10 ° C. The water level has been increased (45 cm) in 
order to increase the sensitivity of the test. The rats lack a sense of 
the water’s depth when their tails do not touch the bottom of the 
cylinder.  
Animals were exposed to a pretest session for 15 min, 24 h prior to 
the 5 min swim test session. Each animal was considered immobile 
when it ceased to struggle and swim and remained floating in the 
water, only moving to keep its head above water. The three 
behaviors scored are defined as follows by Lucki et al. [23]; (1) 
climbing, with the rate making an active attempt to escape from the 
tank, including visual searching for the escape routes and diving; 
climbing may be more related to attempts to escape than is 
swimming; (2) swimming, with the rate staying afloat, pedaling, and 
making circular movements around the tank; and (3) immobility, 
with the rat not making any active movements. 
Procedure-Briefly, a group of 32 rats, was divided at random into 
four groups (n=8) and treated as follows: Group, I (control) received 
2 % gum acacia 10 ml/kg, Group II received sertraline (5 mg/kg), 
Group III received piperine (1 0 mg/kg) and Group IV received 
piperine+sertraline (10+5 mg/kg) all drugs were administered 
orally. Test solutions were administered once daily between 1—3p. 
m. over a period of 14 d. Rats were placed in an acrylic cylinder for 
15 min (pre-test session) after 14 d treatment.  
Twenty-four hours after the pre-test session, the animals were once 
again exposed to the same conditions for 5 min (test session). 
Between the pre-test session and main session drug solutions were 
administered orally three times as follows: just after the pre-test 
session, 5 h before the main test, and 1 h before the main test. A rat 
was judged immobile if it remained floating in the water, except for 
small movements to keep its head above the water. The FST was 
performed between 1-3 p. m. 
Statistical analysis 
The results are presented as mean±SEM. The statistical analysis was 
done using one-way ANOVA followed by multiple Tukey’s 
comparison test. P<0.05 was considered statistically significant. All 
statistical analysis was performed using SPSS 11.5 software. 
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(i) The effect piperine, phenytoin and carbamazepine on MES in 
mice and piperine interaction with carbamazepine: Phenytoin 
abolished the tonic hind limb extension completely and was 100 % 
protective against convulsions. 
While piperine at a dose of 20 and 40 mg/kg decreased the duration of 
tonic hindlimb extension (6.68 and 6.92 s) and incidence of convulsions 
was 37.5 %, i.e. out of eight animals, three animals had convulsions and 
rest five were protected against MES-induced convulsion. 
When carbamazepine was administered in sub anticonvulsant dose, 
it significantly reduced the duration of the tonic hind limb extension 
(9.99 s) as compared to control group (15.70 s), although all the 
eight animals in carbamazepine group developed convulsions i.e. 
100 % incidence of convulsions was seen. 
When carbamazepine was concomitantly administered with 
piperine, it not only significantly reduced the tonic hindlimb 
extension (6.32 s) but also 75 % incidence of convulsion was seen 
i.e. out of eight animals six animals had convulsions while the rest 
two were protected. 
Piperine at a dose of 10 mg/kg did not show any anticonvulsant 
activity.
 
Table 1: The effect of piperine, phenytoin and carbamazepine on MES in mice and piperine interaction with carbamazepine 
Treatment Dose (mg/kg) orally Duration of tonic hindlimb extension in seconds  Incidence of convulsion % 
Control  
(2 % gum acacia)  
10 ml/kg 15.70±0.48 100 
Phenytoin 0.5 - A 
Carbamazepine 15 - A 
Carbamazepine 7.5 9.99±0.38 100 * 
Piperine 10 12.33±0.28 100 
Piperine 20 6.68±0.30 37.5 * 
Piperine 40 6.92±0.43 37.5 * 
Carbamazepine 
+Piperine 
7.5+10 6.32±0.29 75  *,† 








One way ANOVA followed by multiple tukey’s comparisons test., Values are n= 8 mean±SEM, df= 7, 56, * P<0.05 with respect to control, †
 
(ii) Effect of pentobarbitone (40 mg/kg, p. o.) and piperine (10, 20, & 
40 mg/kg) and their combination on righting reflex in rats: 2 % gum 
acacia and piperine at 10, 20 and 40 mg/kg did not showed any loss 
in righting reflex. 
 P<0.05 
with respect to carbamazepine 7.5 mg/kg. A-Absence of convulsion 
Onset of loss of righting reflex with pentobarbitone reached earlier 
when it was combined with piperine. The total duration of sleeping 
was also enhanced when pentobarbitone was combined with 
piperine (P<0.05). 
 
Table 2: Effect of pentobarbitone, piperine and their combination on righting reflex in rats 
Group Dose (mg/kg) (orally) Time of onset (min) Duration (min) 
(2 % gum acacia) 10 ml/kg - - 
Pentobarbitone 40 34.37±1.26 71±2.12 * 
Piperine 
* 
10 - - 
Piperine 20 - - 
Piperine 40 - - 
Pentobarbitone 
+Piperine 
40+10 22.12±1.49 180.37±5.22 *,† 








One way ANOVA followed by multiple tukey’s comparison test., Values are mean±SEM, n=8 in each group, df= 5, 42, * P<0.05 as compared to control, 
†
 
(iii) Effect of midazolam, piperine and their combination on 
behavior of mice in elevated plus maze: Midazolam treated mice 
showed a significant increase in the number of open arm entries, 
preference for the open arm and the time spent in open arm (3.88, 
36.95 & 44.94). They showed a reduction in time spent in the closed 
arms, when compared to control group. 
While the combination of midazolam and piperine showed a greater 
increased preference for open arm when compared with control 
group as well as midazolam alone group. Time spent in the closed 
arm (51.43) was also significantly reduced as compared to 
midazolam alone group. No significant such activity was seen in 
piperine group (P>0.05). 
(iv) Effect of diazepam, piperine and their combination on behavior of 
mice in rotarod: Control (2 % gum acacia) and piperine (10 mg/kg) 
maintained rota rod performance throughout the test period. 
While motor coordination in diazepam alone and its combination 
with piperine group was significantly impaired (P<0.05) as 
compared to control group. Further, in combination group the 
muscle relaxant activity was more significantly impaired in 
comparison with the diazepam alone group (P<0.05). 
(v) The effect piperine, sertraline and their combination on 
immobility period in TST: Sertraline at a dose of 5 mg/kg 
significantly reduces the immobility period (121.44 s) and thereby 
increased the mobility of animals. This effect was further enhanced 
to a significant extent when piperine was combined with sertraline 
(immobility period reduced to 76.53 s). 
 P<0.05 as compared to standard (pentobarbitone) group 
(vi) The effect piperine, sertraline and their combination on 
immobility period in FST: Sertraline when co-administered with 
piperine, reduced the immobility period in FST (125.31 s) which was 
significantly greater than sertraline alone (173.82 s) (P<0.05).
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Number of entries  % preference to open arm Time spent (seconds) 
Open Total Open Closed 
 
(2 % gum acacia) 10 
ml/kg 
2.13±0.48 5.12±1.26 41.60 16.14±0.68 228.93±7.77 
Midazolam 0.2 3.88±0.91 10.50±1.38 36.95 * 44.94±1.73 180.37±3.38* 
Piperine 
* 



















One way ANOVA followed by multiple tukey’s comparison test., Values are mean±SEM. df = 3, 28, *P<0.05, compared to control group, †
 
P<0.05, 
compared to standard (midazolam) group. 
Table 4: Effect of diazepam, piperine and their combination on behavior of mice in rotarod paradigm 




mean time on rotarod after treatment 
60 min 90 min 120 min 240 min 
(2 % gum acacia) 10 ml/kg 60 60 60 60 60 
Diazepam 3 60 47.41±1.02 40.21±0.74* 23.18±1.23* 32.69±1.29* 
Piperine 
* 





60 40.78±0.83 33.87±2.37*† 16.12±1.36*† 24.74±1.22*† *† 
One way ANOVA followed by multiple tukey’s comparison test., Values are mean±SEM. df = 3, 28, *P<0.05, compared to control group, †
 
P<0.05, 
compared to standard (diazepam) group. 
Table 5: The effect of piperine, sertraline and their combination on immobility period in TST 
Treatment Dose (mg/kg) orally Immobility period (seconds) 
Control (2 % gum acacia) 10 ml/kg 191.96±2.45 




Sertraline+Piperine 5+10 76.53±2.68 







One way ANOVA followed by multiple tukey’s comparison test., Values are n= 8 mean±SEM, df= 3, 28, * P<0.05 with respect to control, †
 
 P<0.05 with 
respect to sertraline 
Table 6: The effect of piperine, sertraline and their combination on immobility period in FST 
Treatment Dose (mg/kg) orally X 14 d Immobility period for 5 min (seconds) 
Control (2 % gum acacia) 10 ml/kg 244.74±1.96 




Sertraline+Piperine 5+10 125.31±3.03 







One way ANOVA followed by multiple tukey’s comparison test., Values are n= 8 mean±SEM, df= 3, 28, * P<0.05 with respect to control, †
 
 P<0.05 with 
respect to sertraline 
DISCUSSION 
In the present study piperine isolated from the piper nigrum extract 
was studied for CNS activity using several animal models such as 
MES-induced convulsions, loss of righting reflex, anxiolytic activity, 
muscle relaxant activity and antidepressant activity. The results 
indicated that piperine at a dose of 20 and 40 mg/kg has 
anticonvulsant activity. Apart from that piperine per se does not 
have any significant CNS effect.  
Black pepper has been used as a traditional anticonvulsant in China. 
So we too considered observing its anticonvulsant activity on MES-
induced convulsions in mice. The study revealed the reduction in the 
duration of the hind limb extension and a significant protection 
(62.5 %) against convulsions. Though it was not as protective as 
phenytoin and carbamazepine in which 100 % protection was 
observed. It is also being reported by D’Hooge R et al.[24] that 
intraperitoneal injection of piperine in mice inhibits clonic 
convulsions induced by kainite. Also, they found that seizure activity 
induced by L-glutamate, N-methyl-D-aspartate or guanidino 
succinate was not blunted by piperine. 
In view of its, reported bioenhancing effect, we considered to 
observe the response of piperine along with a subtherapeutic dose 
of carbamazepine. Carbamazepine was selected for the study since 
it’s a drug with low oral bioavailability [25]. Carbamazepine at a 
dose of 15 mg/kg completely abolished hind limb extension with 
100 % protection, while at a dose of 7.5 mg/kg had no protection 
against convulsions. Hence, the dose of 7.5 mg/kg (subtherapeutic) 
was selected to study the combined effect of piperine and 
carbamazepine. The result showed that the duration of hindlimb 
extension was reduced to 6.32 seconds, but protection against 
convulsion was seen in only 25 % of animals i.e. only two animals 
out of eight were protected against convulsions while the rest six 
Mishra et al. 
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had convulsions. It shows that piperine also enhances the 
bioavailability of carbamazepine. (table no. 1)  
To further explore the mechanism of action of the anticonvulsant 
effect of piperine, whether there is some role of GABA, the effect of 
piperine was observed on the righting reflex in rats which was not 
abolished with the increasing graded dose. Thus, it rules out the role 
of GABA in the mechanism of anticonvulsant action of piperine. Also 
in view of enhancing effect the same experiment was repeated in 
combination with pentobarbitone orally. The pentobarbitone 
sleeping time was earlier in onset and enhanced in duration (table 
no. 2). Since piperine is not having any inhibiting effect on GABA, 
hence the enhanced activity of pentobarbitone could be concluded 
as bioenhancing effect. 
This study is also supported by other experiments where the activity 
of midazolam (an antianxiety drug) was assessed in the presence of 
piperine. Elevated plus maze method was used to evaluate the 
activity of midazolam. The number of entries in open arms, increase 
preference towards the open arm and time spent in open arm were 
the criteria for the antianxiety effect. Piperine alone did not produce 
any change in these parameters. However, piperine significantly 
enhanced the effect of midazolam. The antianxiety effect of 
midazolam in the dose of 0.4 mg/kg converted to the sedative effect 
(the animals became drowsy with the loss of their normal 
exploratory nature. They remain immobile at the site where they 
were left). So we reduced the dose of midazolam to 0.2 mg/kg and 
the same study was repeated in presence and absence of piperine. 
Midazolam was little less effective in this reduced dose (table no. 3). 
However, when combined with piperine the effect was nearly equal 
to 0.4 mg/kg of midazolam. It clearly reflects that there is some 
bioenhancing effect on midazolam too.  
The constant observation of an increase in the effect of various 
drugs forced us to think over the bioenhancer effect of piperine. This 
enhancement may be either due to increase in absorption or 
reduction in metabolism of the drug. Our next experiment gave us an 
interesting result that the muscle relaxant effect of diazepam, as 
observed by rotarod method was increased, as suggested by a 
reduction in maintenance time on rotarod though the total duration 
of activity was not increased. It reflects that piperine perhaps 
increases the absorption of diazepam (table no. 4). 
In order to take the advantage of bioenhancer effect in reduction of 
required doses of few more experiments were planned. The 
antidepressant drug sertraline HCl which is having about 60 % oral 
bioavailability as compared to fluoxetine that has about 99 % oral 
bioavailability was taken for the study. 
The study was planned on both acute and chronic depressant 
models in albino mice and rats (tail suspension test and forced swim 
test respectively table no. 5 & 6). Piperine did not show any 
individual effect, but when combined with sertraline a significant 
increase in the immobility period was observed in comparison to 
sertraline alone. It further reflects that there is some increase in the 
bioavailability of sertraline.  
All the experiments suggested that piperine has bio-enhancing 
property. There are various studies which suggest that piperine 
increases the bioavailability of the drugs. The probable mechanisms 
are, by promoting rapid absorption and by increasing the solubility 
of the drugs [26]. It enhances the gastrointestinal blood flow as 
shown by a study done by Annamalai AR et al. [27] and stimulates 
Gamma–glutamyl transpeptidase activity, thereby increasing the 
uptake of drugs by gastrointestinal epithelium [28]. 
Another very important mechanism of action of bio-enhancement is 
by inhibition of drug metabolism by piperine. Piperine has been 
shown to inhibit different cytochrome P450 isoforms as well as 
UDP–glucuronyl transferase and other phase II reactions, thus 
decreasing the metabolism of other drugs [29, 30].  
CONCLUSION 
Piperine has the potential to be used as a bioenhancer when 
combined with various drugs where it would reduce the dose of the 
standard drug and thereby possibly reduce their adverse effects. 
Piperine also has the potential to provide additional benefits in 
anticonvulsant therapy, which will immensely be helpful in reducing 
the adverse effect related to conventional antiepileptic drugs. 
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